SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-12-007979
Filing Date
2012-08-08
Accepted
2012-08-08 16:31:41
Documents
15
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2210334z10-q.htm 10-Q 821106
2 EX-10.1 a2210334zex-10_1.htm EX-10.1 60474
3 EX-10.2 a2210334zex-10_2.htm EX-10.2 57296
4 EX-10.3 a2210334zex-10_3.htm EX-10.3 102767
5 EX-10.4 a2210334zex-10_4.htm EX-10.4 56991
6 EX-31.1 a2210334zex-31_1.htm EX-31.1 7666
7 EX-31.2 a2210334zex-31_2.htm EX-31.2 7680
8 EX-32.1 a2210334zex-32_1.htm EX-32.1 4347
15 G136663KMI001.JPG g136663kmi001.jpg GRAPHIC 2562
  Complete submission text file 0001047469-12-007979.txt   9337073

Data Files

Seq Description Document Type Size
9 EX-101.INS vrtx-20120630.xml EX-101.INS 929276
10 EX-101.SCH vrtx-20120630.xsd EX-101.SCH 138638
11 EX-101.CAL vrtx-20120630_cal.xml EX-101.CAL 83745
12 EX-101.LAB vrtx-20120630_lab.xml EX-101.LAB 2038718
13 EX-101.PRE vrtx-20120630_pre.xml EX-101.PRE 853845
14 EX-101.DEF vrtx-20120630_def.xml EX-101.DEF 513109
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 121017235
SIC: 2834 Pharmaceutical Preparations